Active Pharmaceutical Ingredient (API)
Canagliflozin
SGLT2 Inhibitor (Antidiabetic)
A newer SGLT2 inhibitor used for Type 2 Diabetes. It lowers blood glucose by blocking the SGLT2 transporter in the kidneys, leading to glucose excretion in the urine, offering cardiovascular and renal protective benefits.
Technical Profile
- Reference Code
- CAN552
- CAS Number
- 842133-18-0
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Canagliflozin as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Invokana 100mg H | Johnson & Johnson Ltd | Tablet (100 mg) | ₹1,150.00 | View Details |
| Invokana 100 H | Janssen Pharmaceuticals | Tablet (100 mg) | ₹553.00 | View Details |
| Prominad 100 H | Cipla Ltd | Tablet (100 mg) | ₹385.00 | View Details |
| Motivyst 300 H | Janssen Pharmaceuticals | Tablet (300 mg) | ₹1,320.00 | View Details |
| Sulisent 100 H | Sun Pharmaceutical Industries Ltd | Tablet (100 mg) | ₹549.00 | View Details |
| Canaglyn 300 H | Zydus Lifesciences Ltd | Tablet (300 mg) | ₹600.00 | View Details |